Friday, 11 October 2019

Eli Lilly's migraine treatment wins U.S. FDA approval

The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly and Co's migraine drug, Reyvow.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)